Real-time enrollment status for this ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 4:23 PM UTC
| NCT Number | NCT06302439 |
| Recruiting Status | Recruiting |
| Condition | Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 1,000 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Inozyme Pharma |
| Last Updated on CT.gov | December 22, 2025 (Dec 22, 2025) |
As of July 13, 2026: Clinical trial NCT06302439 is currently recruiting participants. This clinical trial study for ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency is actively seeking new participants at 5 locations across the United States. The study is sponsored by Inozyme Pharma. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06302439 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06302439 was last updated Dec 22, 2025 (December 22, 2025). HelloStudys verifies this status automatically.